PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.32) by 67.19 percent. This is a 51.43 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $76.383 million which missed the analyst consensus estimate of $94.137 million by 18.86 percent. This is a 11.94 percent increase over sales of $68.236 million the same period last year.